|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.575 USD | -2.16% |
|
-0.08% | -0.83% |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| 05-11 | Evolus Plans to Launch Estyme Collection in Europe | MT |
| Market Cap | 443M 384M 354M 332M 620M 42.37B 633M 4.22B 1.63B 20.43B 1.66B 1.63B 71.02B | P/E Ratio 2026 * |
-13.5x | P/E Ratio 2027 * | -45.8x |
|---|---|---|---|---|---|
| Enterprise Value | 570M 494M 456M 427M 798M 54.53B 814M 5.43B 2.1B 26.29B 2.14B 2.09B 91.4B | EV / Sales 2026 * |
1.72x | EV / Sales 2027 * | 1.48x |
| Free-Float |
83.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evolus, Inc.
| 1 day | -1.93% | ||
| 1 week | -0.08% | ||
| Current month | +0.53% | ||
| 1 month | +4.35% | ||
| 3 months | +22.36% | ||
| 6 months | -4.56% | ||
| Current year | -0.83% |
| 1 week | 6.36 |  | 6.94 |
| 1 month | 5.95 | | 6.94 |
| Current year | 3.86 | | 6.94 |
| 1 year | 3.86 | | 10.33 |
| 3 years | 3.86 | | 17.82 |
| 5 years | 3.86 | | 17.82 |
| 10 years | 2.85 | | 39.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 48 | 2018-05-05 |
Tatjana Mitchell
DFI | Director of Finance/CFO | 48 | 2025-09-07 |
Jon Yerbury
COO | Chief Operating Officer | - | 2022-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Vikram Malik
CHM | Chairman | 63 | 2017-12-31 |
David Gill
BRD | Director/Board Member | 71 | 2018-02-11 |
David Moatazedi
BRD | Director/Board Member | 48 | 2018-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-19 | Sell | Chief Technology Officer | 3,119 | 0.0048% | ||
| 03-19 | Sell | Chief Executive Officer | 13,669 | 0.0211% | ||
| 03-15 | Fiscal year | Chief Technology Officer | 47,604 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -0.08% | -35.60% | -19.87% | 443M | |
| +2.34% | +3.58% | +44.14% | +161.73% | 1,013B | |
| +0.36% | +5.01% | +54.32% | +49.84% | 574B | |
| +0.76% | +0.78% | +18.37% | +64.59% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +5.38% | +2.67% | +21.59% | +63.24% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +4.24% | -1.98% | +15.85% | +62.63% | 151B | |
| Average | +1.34% | +3.52% | +14.44% | +39.83% | 338.91B | |
| Weighted average by Cap. | +1.51% | +3.99% | +29.91% | +73.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 330M 287M 264M 248M 463M 31.64B 472M 3.15B 1.22B 15.25B 1.24B 1.21B 53.03B | 388M 336M 310M 291M 543M 37.12B 554M 3.7B 1.43B 17.89B 1.46B 1.42B 62.21B |
| Net income | -33.31M -28.9M -26.64M -24.96M -46.64M -3.19B -47.62M -318M -123M -1.54B -125M -122M -5.35B | -10.56M -9.17M -8.45M -7.92M -14.79M -1.01B -15.1M -101M -39.02M -487M -39.65M -38.79M -1.69B |
| Net Debt | 127M 110M 102M 95.19M 178M 12.16B 182M 1.21B 469M 5.86B 477M 466M 20.38B | 132M 115M 106M 98.94M 185M 12.64B 189M 1.26B 488M 6.09B 496M 485M 21.18B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 6.595 $ | -1.86% | 342,695 |
| 26-06-10 | 6.720 $ | +0.30% | 671,004 |
| 26-06-09 | 6.700 $ | +0.30% | 774,749 |
| 26-06-08 | 6.680 $ | +0.15% | 750,013 |
| 26-06-05 | 6.670 $ | +1.06% | 706,612 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EOLS Stock
Select your edition
All financial news and data tailored to specific country editions
